Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Clinical Development


Parexel to lay off up to 125 transferred GSK employees

31-Jul-2015 - Beginning Sept. 30, Massachusetts-based CRO (contract research organization) Parexel will lay off as many as 125 of the 450 employees it brought on from GlaxoSmithKline (GSK) in North Carolina late last...

Charles River renews early-stage partnership with AstraZeneca for five years

31-Jul-2015 - Contract research organization Charles River Laboratories has extended its initial three-year strategic partnership with AstraZeneca for an additional five years. 

INC Research raises guidance for 2015, stock jumps 10%

31-Jul-2015 - Contract research organization INC Research reported 14.2% net service revenue growth in Q2, compared to the same quarter last year, raised future guidance and saw its stock bump up more than 10%.

Expansions of in-house R&D will have no impact on CROs, say Pfizer and Lilly

30-Jul-2015 - Despite expanding their in-house R&D facilities, both Pfizer and Eli Lilly say they remain committed to using CROs.

Growth in biopharma industry buttressing Quintiles’ quarterly earnings

30-Jul-2015 - Consistent Q2 growth for the world’s largest CRO (contract research organization) Quintiles was driven by a spike in the company’s Integrated Healthcare Services (IHS) segment.

Covance acquisition begins paying off for LabCorp in Q2

30-Jul-2015 - LabCorp revealed a more than 46% increase in quarterly revenue from the same quarter last year as the recent $6.2bn acquisition of Covance brought in $620.8m of the overall company’s...


CRO vs HRA trial transparency case ends in a win for industry

29-Jul-2015 - A five-month legal battle over the duties of trial sponsors to publish results has ended with a judge ruling the UK regulator acted unlawfully and sponsors will not be required to...

Icon puts up record net new business wins in Q2

29-Jul-2015 - CRO (contract research organization) Icon reported its highest level of quarterly bookings ever on Tuesday and the company’s stock jumped by about 15%. 

PRA acquires small clinical development software company for $2.5m

29-Jul-2015 - CRO (contract research organization) PRA Health Sciences reported in its earnings call on Tuesday that earlier in Q2 it acquired Value Health Solutions (VHS), a clinical development software company, for...

Biologic services demand pushes BioOutsource to open new Glasgow facility

28-Jul-2015 - A surge of demand in biologics contract testing and biosimilar characterization has caused BioOutsource to double its capacity with the opening of a new facility in Glasgow, Scotland.

Indian government task force calls to simplify clinical trial approval process

28-Jul-2015 - As the number of approved clinical trials in India continues to taper off compared to years past, a government task force is now calling for a new expedited trial approval...

LabCorp’s Covance expands clinical research unit in Texas

28-Jul-2015 - LabCorp’s Covance Drug Development has relocated its clinical research unit (CRU) in Dallas, TX, to a new facility with 28 more medical beds. 

Funds worth €3.5tr back Alltrials, but none promise to pull cash from drug firms that don't

23-Jul-2015 - Investor backing puts transparency on the pharma agenda says SenseAboutScience, even though none of the funds pledging support for Alltrials have committed to pull investment from drug firms that disagree.

Research consortium looks to identify biomarkers for autism treatments

21-Jul-2015 - A new four-year research project involving a consortium of government, non-profit and other large biopharma partners is aiming to create a set of measures that can be used in clinical...

PRA gets creative in attracting more top talent

21-Jul-2015 - In an industry with high employee turnover rates, CROs (contract research organizations) are now turning to new, creative ways to try to recruit and retain top talent.

Biocon: IPO will evolve Syngene CRO into full manufacturing services firm

20-Jul-2015 - Indian CRO Syngene has received approval for its IPO prospectus paving the way to spin out from its parent company Biocon.

CRO Frontage acquires minority stake in BDM Consulting

17-Jul-2015 - Full-service CRO (contract research organization) Frontage Laboratories has acquired a 45% stake in BDM Consulting to expand its offerings in biostatistics, data management and SAS (statistical analysis system) programming.

Data management, SOP deficiencies cited often after 2014 GCP inspections, EMA report finds

16-Jul-2015 - The latest EMA (European Medicines Agency) report on GCP (good clinical practice) inspections reveals that deficiencies around SOPs (standard operating procedures), sponsor monitoring, data management, and essential documents linked to...

AB Science hit with FDA warning letter over clinical trials

16-Jul-2015 - France’s AB Science has received a warning letter from the US FDA for its failure to adhere to agency regulations and to protect trial subjects’ safety in a pancreatic cancer...

Risk/profit-sharing in clinical trials progresses with Nuvelution launch

15-Jul-2015 - With an exclusive board of directors and now some funding, Nuvelution Pharma is looking to get its risk-sharing clinical trial venture for late-stage candidates off the ground and will engage...

News in brief

Icon’s lab services group partners with Cancer Genetics on range of testing services

14-Jul-2015 - DNA-based diagnostics company Cancer Genetics has partnered with the lab services group of CRO Icon to provide clients with new offerings, including oncology-focused genomic testing, central lab analysis, project and data...

US House passes 21st Century Cures Act

10-Jul-2015 - With an overwhelming majority, the House on Friday morning passed a new bipartisan bill that would increase NIH funding by about $8.75bn and the FDA by $550m over the next...

Epic Sciences expands partnership with LabCorp’s Covance in Asia

09-Jul-2015 - Epic and LabCorp’s Covance have agreed to extend their partnership to provide circulating tumor cell (CTC) technology and oncology clinical trial support in Asia. 

Revised 21st Century Cures bill takes a step back on NIH research transparency

07-Jul-2015 - With a House floor vote looming this week, legislators will decide on a revised bill that has decreased the amount of funding that will go to the NIH from the...

European analytical lab network to speed nanomedicines to market

07-Jul-2015 - The EU has launched a €5m ($5.5m) programme across six facilities for characterising European nanomedicines.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...